Laurion Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Laurion Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,700	Closed	-$357K	–	1405
2019 Q2	$357K	Buy	+7,700	New	+$216K	﹤0.01%	754
2017 Q4	–	Sell	-119,221	Closed	-$1.47M	–	2000
2017 Q3	$1.47M	Buy	+119,221	New	+$1.11M	0.01%	857
2016 Q4	–	Sell	-150,000	Closed	-$1.01M	–	1368
2016 Q3	$1.01M	Buy	+150,000	New	+$580K	0.01%	568

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Laurion Capital Management's ARRY Position: Q3 2019 in Review

Laurion Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 7,700 shares — an estimated $357K sold.

Laurion Capital Management first reported a position in ARRY in Q3 2016 and held it in 3 quarters. The position peaked at $1.47M in Q3 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Laurion Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Laurion Capital Management sold 7,700 Array Biopharma Inc shares in Q3 2019, an estimated $357K.
Laurion Capital Management first reported a position in Array Biopharma Inc in Q3 2016 and held it in 3 quarters.
Laurion Capital Management's Array Biopharma Inc position peaked at $1.47M in Q3 2017.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Laurion Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.